title: The interplay between microbiota and inflammation: lessons from peritonitis and sepsis.
abstract: Mammals harbor a complex gut-associated microbiota, comprising bacteria that provide immunological, metabolic and neurological benefits to the host, and contribute to their well-being. However, dysregulation of the microbiota composition, known as dysbiosis, along with the associated mucosal immune response have a key role in the pathogenesis of many inflammatory diseases, including inflammatory bowel diseases (IBDs), type 1 and type 2 diabetes, asthma, multiple sclerosis, among others. In addition, outside the gut lumen, bacteria from microbiota are the causative agent of peritoneal inflammation, abdominal sepsis and systemic sepsis. Critical care interventions during sepsis by antibiotics induce dysbiosis and present acute and long-term poor prognosis. In this review, we discuss immunomodulatory effects of the microbial molecules and products, highlighting the role of Bacteroides fragilis, a human commensal with ambiguous interactions with the host. Moreover, we also address the impact of antibiotic treatment in sepsis outcome and discuss new insights for microbiota modulation.
authors.affiliation: Departamento de Microbiologia Médica, Instituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro-UFRJ , Rio de Janeiro, Brazil.
authors.forename: Leandro A
authors.initials: LA
authors.lastname: Lobo
authors.affiliation: Programa de Imunobiologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro-UFRJ , Rio de Janeiro, Brazil.
authors.forename: Claudia F
authors.initials: CF
authors.lastname: Benjamim
authors.affiliation: Programa de Imunobiologia, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro-UFRJ , Rio de Janeiro, Brazil.
authors.forename: Ana Carolina
authors.initials: AC
authors.lastname: Oliveira